🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kevin Kalinsky

Emory University

ORCID: 0000-0002-1583-3553

Also affiliated with Columbia University Irving Medical Center, Cancer Institute (WIA), Piedmont Cancer Institute, Winship Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial”.

Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae314
N/A
0.443DataRank · unranked
10 citations

William E. Barlow, Julie R. Gralow, Funda Meric‐Bernstam, Kathy S. Albain, Daniel F. Hayes +19 more

Therapeutic benefits of maintaining CDK4/6 inhibitors and incorporating CDK2 inhibitors beyond progression in breast cancer

eLife(2025)10.7554/elife.104545
N/A
0.275DataRank · unranked
4 citations

Sungsoo Kim, Kibum Kim, Eugene Son, Minah Kim, Kevin Kalinsky +2 more

Quantitative Multiplex Immunofluorescence Evaluation of the Tumor Microenvironment in Pretreatment Tumors of Patients with Metastatic Breast Cancer and Serous Ovarian Carcinoma Treated with Liposomal Eribulin

Cancer Investigation(2021)10.1080/07357907.2021.1938109
N/A
0DataRank · unranked
0 citations

John Kucharczyk, Pan Kim, Donian Chyong, Robyn D. Gartrell, Yan Lu +9 more

Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer

Clinical Breast Cancer(2022)10.1016/j.clbc.2022.04.002
N/A
0DataRank · unranked
18 citations

Kathleen Fenn, Matthew Kearney, Qi Wang, Hua Guo, Douglas K. Marks +11 more

Use of a convolutional neural network-based mammographic evaluation to predict breast cancer recurrence among women with hormone receptor-positive operable breast cancer

Breast Cancer Research and Treatment(2022)10.1007/s10549-022-06614-3
N/A
0DataRank · unranked
3 citations

Vicky Ro, Simukayi Mutasa, Samuel Pan, Jianhua Hu, Meghna S. Trivedi +6 more

Pharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancers

Journal of Clinical Investigation(2024)10.1172/jci176390
N/A
0DataRank · unranked
30 citations

Anupam Banerjee, Ping Xie, Andrei A. Ivanov, Amad Uddin, Qiao Jiao +16 more

Network-based assessment of HDAC6 activity is highly predictive of pre-clinical and clinical responses to the HDAC6 inhibitor ricolinostat

medRxiv(2020)10.1101/2020.04.23.20066928
N/A
0DataRank · unranked
5 citations

Qingfei Pan, Cody Chiuzan, Maika Onishi, Mariano J. Alvarez, Erin Honan +17 more

Therapeutic benefits of maintaining CDK4/6 inhibitors and incorporating CDK2 inhibitors beyond progression in breast cancer

eLife(2025)10.7554/elife.104545.2
N/A
0DataRank · unranked
0 citations

Sungsoo Kim, Kibum Kim, Eugene Son, Minah Kim, Kevin Kalinsky +2 more

Reconstructing tumor trajectories during therapy through integration of multiple measurement modalities

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.14.426737
N/A
0DataRank · unranked
2 citations

Jinfeng Chen, Onalisa Winblad, Anne O’Dea, Priyanka Sharma, Meghna S. Trivedi +13 more